Disc Medicine (IRON) Other Non-Current Assets (2020 - 2026)
Disc Medicine (IRON) reported Other Non-Current Assets of $721000.0 for Q1 2026, down 14.06% year-over-year from $839000.0 in Q1 2025, and down 0.69% on a QoQ basis from $726000.0 in Q4 2025.
Disc Medicine (IRON) has 7 years of Other Non-Current Assets data on file, last reported at $721000.0 in Q1 2026.
- Quarterly Other Non-Current Assets fell 14.06% year-over-year to $721000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $721000.0 (down 14.06% YoY) and the FY2025 annual result came in at $726000.0, down 13.37% from the prior year.
- Other Non-Current Assets slipped to $721000.0 in Q1 2026 per IRON's latest filing, from $726000.0 in the prior quarter.
- Across five years, Other Non-Current Assets topped out at $1.4 million in Q3 2022 and bottomed at $116000.0 in Q4 2022.
- The 5-year median for Other Non-Current Assets is $236000.0 (2024), against an average of $470411.8.
- The widest annual swing landed in 2022, when Other Non-Current Assets surged 355.67%; it then tumbled 91.51% in 2023.
- Tracing IRON's Other Non-Current Assets over 5 years: stood at $116000.0 in 2022, then soared by 101.72% to $234000.0 in 2023, then jumped by 258.12% to $838000.0 in 2024, then decreased by 13.37% to $726000.0 in 2025, then retreated by 0.69% to $721000.0 in 2026.
- Per Business Quant, the three latest IRON Other Non-Current Assets figures stand at $721000.0 (Q1 2026), $726000.0 (Q4 2025), and $840000.0 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 12.40 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 60,000.00 |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 1.26 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 2.13 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 63.55 Mn |
| 10 | Disc Medicine | 2.76 Bn | 2.03 Bn | - | 721,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 721,000.00 |
| Dec 31, 2025 | 726,000.00 |
| Sep 30, 2025 | 840,000.00 |
| Jun 30, 2025 | 840,000.00 |
| Mar 31, 2025 | 839,000.00 |
| Dec 31, 2024 | 838,000.00 |
| Sep 30, 2024 | 236,000.00 |
| Jun 30, 2024 | 236,000.00 |
| Mar 31, 2024 | 235,000.00 |
| Dec 31, 2023 | 234,000.00 |
| Sep 30, 2023 | 116,000.00 |
| Jun 30, 2023 | 116,000.00 |
| Mar 31, 2023 | 116,000.00 |
| Dec 31, 2022 | 116,000.00 |
| Sep 30, 2022 | 1.37 Mn |
| Jun 30, 2022 | 204,000.00 |
| Mar 31, 2022 | 217,000.00 |
| Dec 31, 2021 | 180,000.00 |
| Sep 30, 2021 | 300,000.00 |
| Jun 30, 2021 | 559,000.00 |
| Mar 31, 2021 | 323,000.00 |
| Dec 31, 2020 | 2.64 Mn |